Stebbings H and van Bueren J |
Stability of microtubules from insect ovarioles. |
1981 |
Cell Biol. Int. Rep. |
pmid:7273149
|
Tanida S et al. |
Ansamitocin analogs from a mutant strain of Nocardia. I. Isolation of the mutant, fermentation and antimicrobial properties. |
1981 |
J. Antibiot. |
pmid:7275830
|
Izawa M et al. |
Ansamitocin analogs from a mutant strain of Nocardia. II. Isolation and structure. |
1981 |
J. Antibiot. |
pmid:7275831
|
Luduena RF and Roach MC |
Contrasting effects of maytansine and vinblastine on the alkylation of tubulin sulfhydryls. |
1981 |
Arch. Biochem. Biophys. |
pmid:7305339
|
Edmonson JH et al. |
Phase II study of maytansine in advanced breast cancer. |
1981 May-Jun |
Cancer Treat Rep |
pmid:7237478
|
Ono Y et al. |
Antitumor and cytocidal activities of a newly isolated benzenoid ansamycin, macbecin I. |
1982 |
Gan |
pmid:6186564
|
Creech RH et al. |
Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578). |
1982 |
Cancer Treat Rep |
pmid:6282460
|
Ratanatharathorn V et al. |
Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study. |
1982 |
Cancer Treat Rep |
pmid:7093975
|
Hatano K et al. |
Biosynthetic origin of aminobenzenoid nucleus (C7N-unit) of ansamitocin, a group of novel maytansinoid antibiotics. |
1982 |
J. Antibiot. |
pmid:7174527
|
Borden EC et al. |
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas. |
1982 |
Am. J. Clin. Oncol. |
pmid:6956236
|
Slavik M et al. |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience. |
1982 |
Am. J. Clin. Oncol. |
pmid:6897490
|
Perdue RE |
KB cell culture I. Role in discovery of antitumor agents from higher plants. |
1982 Jul-Aug |
J. Nat. Prod. |
pmid:7130986
|
deVere White R et al. |
Maytansine as a cause of acute proliferative disorder of bladder urothelium in the rat. |
1983 |
Cancer Treat Rep |
pmid:6825127
|
Thigpen JT et al. |
Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary. A Gynecologic Oncology Group study. |
1983 |
Am. J. Clin. Oncol. |
pmid:6846245
|
Edmonson JH et al. |
Phase II study of maytansine in advanced sarcomas. |
1983 |
Cancer Treat Rep |
pmid:6850657
|
Thigpen JT et al. |
Phase II study of maytansine in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. |
1983 |
Am. J. Clin. Oncol. |
pmid:6869315
|
Ghetti B and Gambetti P |
Comparative immunocytochemical characterization of neurofibrillary tangles in experimental maytansine and aluminum encephalopathies. |
1983 |
Brain Res. |
pmid:6354362
|
Fan YJ et al. |
[Use of 1,2:5,6-dianhydrogalactitol in combination with maytansine in experimental tumor therapy]. |
1983 |
Yao Xue Xue Bao |
pmid:6677049
|
Sabio H et al. |
Maytansine in refractory childhood acute lymphocytic leukemia: a Pediatric Oncology Group study. |
1983 |
Cancer Treat Rep |
pmid:6580069
|
Tsuruo T et al. |
Establishment and properties of vincristine-resistant human myelogenous leukemia K562. |
1983 |
Gan |
pmid:6580255
|